单位:[1]Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, PR China内科学系大内科心血管内科华中科技大学同济医学院附属同济医院[2]Key Laboratory of Vascular Aging, Ministry of Education, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, PR China华中科技大学同济医学院附属同济医院
第一作者单位:[1]Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, PR China
通讯作者:
通讯机构:[1]Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, PR China[2]Key Laboratory of Vascular Aging, Ministry of Education, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, PR China
推荐引用方式(GB/T 7714):
Men Lintong,Lin Li,Guo Junyi.PERK inhibition in hearts: angel or devil?[J].TRENDS IN MOLECULAR MEDICINE.2023,29(8):581-582.doi:10.1016/j.molmed.2023.05.004.
APA:
Men Lintong,Lin Li&Guo Junyi.(2023).PERK inhibition in hearts: angel or devil?.TRENDS IN MOLECULAR MEDICINE,29,(8)
MLA:
Men Lintong,et al."PERK inhibition in hearts: angel or devil?".TRENDS IN MOLECULAR MEDICINE 29..8(2023):581-582